Home  >  Research  >  Labs  >  Centres & Facilities  >  Proteomics


Proteomics International is a medical technology company that specialises in proteomics, or the industrial-scale study of the structure and functions of proteins. Proteomics International operates from the Harry Perkins Institute of Medical Research, and is recognised as a world leader in the field of proteomics. Proteomics specialises in predictive diagnostics and bio-analytics services.


Proteomics International aims to develop and commercialise diagnostic tests for chronic disease where there is unmet medical need. Across three divisions – analytical services, diagnostics and therapeutics – Proteomics provides a range of services on a fee-for-service basis, including:

  • Pharmacokinetic Testing
  • Biosimilars/Biologics Drug Characterisation
  • Proteome Mapping
  • Protein Quantitation
  • Targeted Mass Spectrometry
  • Protein ID by Mass Spectrometry
  • Post-translational Modifications (PTMs)


Proteomics International was established in 2001, with almost two decades of experience in providing specialised analytical services built around proteomics-based technology. In addition to the Perkins, Proteomics International provides services to groups throughout the Indo-Asian region, with offices in India, Japan, Singapore, Malaysia and Hong Kong.

Get in touch

T: +61 8 9389 1992
E: [email protected]